New drug to suppress allergies, asthma

Image
IANS Melbourne
Last Updated : Nov 25 2016 | 8:28 AM IST

An Australian Nobel Prize-winning scientist is developing a drug to counter allergies and asthma, a statement said on Friday.

Still in its initial stage the the drug can be taken as tablets, capsules, liquids or powder, Xinhua news reported.

Barry Marshall, a microbiology professor from University of Western Australia, who won the Nobel Prize in Physiology in 2005 for stomach ulcer research, is working on the new drug.

The medication, named Immbalance, aims to suppress an overactive immune system.

"This actually arose from work we were doing on helicobacter, the stomach bug, for which Robin Warren and I won the Nobel Prize a few years ago," Marshall said on Friday.

"We've discovered the way it survives in your body is by suppressing the immune system so you can't get rid of it.

"I can't guarantee that it's going to cure allergy sufferers... we think this kind of thing will bring people who are hyper reactive... down into the normal range."

Marshall, who spent the last seven years developing the drug, said that it can be formulated as tablets, capsules, liquids or powder.

"Children could spread the powder on their cereal or put it in a drink and over the course of a few months could suppress their allergic response," he said in a UWA media release.

"We think it's going to be 100 percent safe. It won't remove your immune system; it will just take the edge off."

--IANS

in/

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 25 2016 | 8:18 AM IST

Next Story